The accelerated global introduction of IPV faced severe supply constraints, highlighting the need for cautious supply commitments and clear allocation criteria in future global health programs.
No takes yet. Share an insight, caveat, or question.
Ongoing IPV shortages require cautious campaign planning; leaves open sustainable supply strategies for global programs.
Lewis et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: